UniProt ID | MFN2_HUMAN | |
---|---|---|
UniProt AC | O95140 | |
Protein Name | Mitofusin-2 | |
Gene Name | MFN2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 757 | |
Subcellular Localization |
Mitochondrion outer membrane Multi-pass membrane protein . Colocalizes with BAX during apoptosis. |
|
Protein Description | Mitochondrial outer membrane GTPase that mediates mitochondrial clustering and fusion. [PubMed: 11181170] | |
Protein Sequence | MSLLFSRCNSIVTVKKNKRHMAEVNASPLKHFVTAKKKINGIFEQLGAYIQESATFLEDTYRNAELDPVTTEEQVLDVKGYLSKVRGISEVLARRHMKVAFFGRTSNGKSTVINAMLWDKVLPSGIGHTTNCFLRVEGTDGHEAFLLTEGSEEKRSAKTVNQLAHALHQDKQLHAGSLVSVMWPNSKCPLLKDDLVLMDSPGIDVTTELDSWIDKFCLDADVFVLVANSESTLMQTEKHFFHKVSERLSRPNIFILNNRWDASASEPEYMEEVRRQHMERCTSFLVDELGVVDRSQAGDRIFFVSAKEVLNARIQKAQGMPEGGGALAEGFQVRMFEFQNFERRFEECISQSAVKTKFEQHTVRAKQIAEAVRLIMDSLHMAAREQQVYCEEMREERQDRLKFIDKQLELLAQDYKLRIKQITEEVERQVSTAMAEEIRRLSVLVDDYQMDFHPSPVVLKVYKNELHRHIEEGLGRNMSDRCSTAITNSLQTMQQDMIDGLKPLLPVSVRSQIDMLVPRQCFSLNYDLNCDKLCADFQEDIEFHFSLGWTMLVNRFLGPKNSRRALMGYNDQVQRPIPLTPANPSMPPLPQGSLTQEEFMVSMVTGLASLTSRTSMGILVVGGVVWKAVGWRLIALSFGLYGLLYVYERLTWTTKAKERAFKRQFVEHASEKLQLVISYTGSNCSHQVQQELSGTFAHLCQQVDVTRENLEQEIAAMNKKIEVLDSLQSKAKLLRNKAGWLDSELNMFTHQYLQPSR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 (in isoform 2) | Phosphorylation | - | 35.57 | 24043423 | |
6 | Phosphorylation | --MSLLFSRCNSIVT --CCCHHHCCCEEEE | 35.57 | 29514088 | |
7 (in isoform 2) | Phosphorylation | - | 19.12 | 24043423 | |
9 (in isoform 2) | Phosphorylation | - | 33.39 | 24043423 | |
10 | Phosphorylation | LLFSRCNSIVTVKKN CHHHCCCEEEEEECC | 23.28 | 25159151 | |
13 | Phosphorylation | SRCNSIVTVKKNKRH HCCCEEEEEECCCCC | 25.57 | 29514088 | |
27 | Phosphorylation | HMAEVNASPLKHFVT CCEECCCCHHHHHHH | 26.09 | 25159151 | |
30 | Ubiquitination | EVNASPLKHFVTAKK ECCCCHHHHHHHHHH | 38.08 | 32015554 | |
36 | Acetylation | LKHFVTAKKKINGIF HHHHHHHHHHHCHHH | 45.28 | 88527 | |
36 | Ubiquitination | LKHFVTAKKKINGIF HHHHHHHHHHHCHHH | 45.28 | 23503661 | |
70 | Phosphorylation | NAELDPVTTEEQVLD CCCCCCCCCHHHHHC | 33.60 | 20068231 | |
71 | Phosphorylation | AELDPVTTEEQVLDV CCCCCCCCHHHHHCH | 37.45 | 20068231 | |
79 | Ubiquitination | EEQVLDVKGYLSKVR HHHHHCHHHHHHHHC | 41.32 | 21906983 | |
79 (in isoform 1) | Ubiquitination | - | 41.32 | 21890473 | |
84 | Ubiquitination | DVKGYLSKVRGISEV CHHHHHHHHCCHHHH | 33.10 | 27667366 | |
89 | Phosphorylation | LSKVRGISEVLARRH HHHHCCHHHHHHHCC | 25.20 | 23909892 | |
98 | Ubiquitination | VLARRHMKVAFFGRT HHHHCCCEEEEEEEC | 25.04 | - | |
105 (in isoform 2) | Ubiquitination | - | 27.24 | 21890473 | |
105 | Phosphorylation | KVAFFGRTSNGKSTV EEEEEEECCCCCCCE | 27.24 | 22210691 | |
111 | Phosphorylation | RTSNGKSTVINAMLW ECCCCCCCEEEHHHC | 28.97 | 23620051 | |
115 (in isoform 2) | Ubiquitination | - | 5.37 | 21890473 | |
119 (in isoform 2) | Ubiquitination | - | 27.50 | 21890473 | |
154 (in isoform 1) | Ubiquitination | - | 47.83 | 21890473 | |
154 | Ubiquitination | LTEGSEEKRSAKTVN ECCCCHHHHHHHHHH | 47.83 | 21906983 | |
158 (in isoform 1) | Ubiquitination | - | 55.01 | 21890473 | |
158 | Ubiquitination | SEEKRSAKTVNQLAH CHHHHHHHHHHHHHH | 55.01 | 21906983 | |
159 (in isoform 2) | Ubiquitination | - | 25.14 | 21890473 | |
171 (in isoform 1) | Ubiquitination | - | 48.46 | 21890473 | |
171 | Ubiquitination | AHALHQDKQLHAGSL HHHHHHCCCCCCCCE | 48.46 | 22817900 | |
192 | Ubiquitination | NSKCPLLKDDLVLMD CCCCCCCCCCEEEEC | 57.80 | - | |
243 | Acetylation | TEKHFFHKVSERLSR HHHHHHHHHHHHHCC | 42.15 | 19608861 | |
243 | Ubiquitination | TEKHFFHKVSERLSR HHHHHHHHHHHHHCC | 42.15 | 19608861 | |
249 | Phosphorylation | HKVSERLSRPNIFIL HHHHHHHCCCCEEEE | 52.49 | 20873877 | |
282 | Phosphorylation | RQHMERCTSFLVDEL HHHHHHHHHHHHHHC | 28.83 | 28348404 | |
283 | Phosphorylation | QHMERCTSFLVDELG HHHHHHHHHHHHHCC | 21.87 | 28348404 | |
307 (in isoform 1) | Ubiquitination | - | 40.63 | 21890473 | |
307 | Ubiquitination | RIFFVSAKEVLNARI EEEEEEHHHHHHHHH | 40.63 | 21906983 | |
316 (in isoform 1) | Ubiquitination | - | 40.06 | 21890473 | |
316 | Ubiquitination | VLNARIQKAQGMPEG HHHHHHHHHCCCCCC | 40.06 | 21906983 | |
355 | Acetylation | CISQSAVKTKFEQHT HHCHHHHHHHHHHHC | 45.79 | 20167786 | |
355 | Ubiquitination | CISQSAVKTKFEQHT HHCHHHHHHHHHHHC | 45.79 | 21963094 | |
357 | Ubiquitination | SQSAVKTKFEQHTVR CHHHHHHHHHHHCHH | 40.98 | 22817900 | |
366 | Ubiquitination | EQHTVRAKQIAEAVR HHHCHHHHHHHHHHH | 31.50 | 27667366 | |
402 | Ubiquitination | EERQDRLKFIDKQLE HHHHHHHHHHHHHHH | 40.96 | 23000965 | |
406 | Ubiquitination | DRLKFIDKQLELLAQ HHHHHHHHHHHHHHH | 52.55 | 23000965 | |
406 (in isoform 1) | Ubiquitination | - | 52.55 | 21890473 | |
416 (in isoform 1) | Ubiquitination | - | 39.31 | 21890473 | |
416 | Ubiquitination | ELLAQDYKLRIKQIT HHHHHHHHHHHHHHH | 39.31 | 23000965 | |
420 | Ubiquitination | QDYKLRIKQITEEVE HHHHHHHHHHHHHHH | 29.25 | 23000965 | |
420 (in isoform 1) | Ubiquitination | - | 29.25 | 21890473 | |
423 | Phosphorylation | KLRIKQITEEVERQV HHHHHHHHHHHHHHH | 24.49 | - | |
442 | Phosphorylation | AEEIRRLSVLVDDYQ HHHHHHHHHHHHCCC | 16.16 | 16762064 | |
460 | Ubiquitination | HPSPVVLKVYKNELH CCCCEEEEEHHHHHH | 31.73 | 21906983 | |
460 (in isoform 1) | Ubiquitination | - | 31.73 | 21890473 | |
463 | Ubiquitination | PVVLKVYKNELHRHI CEEEEEHHHHHHHHH | 47.11 | 27667366 | |
560 | Ubiquitination | VNRFLGPKNSRRALM HHHHHCCCCHHCHHC | 66.80 | 32142685 | |
611 | Phosphorylation | VTGLASLTSRTSMGI HHHHHHHCCCCCCEE | 17.42 | 24719451 | |
651 | Phosphorylation | LYVYERLTWTTKAKE HHHHHHHHCCHHHHH | 27.30 | 25278378 | |
653 | Phosphorylation | VYERLTWTTKAKERA HHHHHHCCHHHHHHH | 17.12 | 25278378 | |
654 | Phosphorylation | YERLTWTTKAKERAF HHHHHCCHHHHHHHH | 22.14 | 25278378 | |
655 | Ubiquitination | ERLTWTTKAKERAFK HHHHCCHHHHHHHHH | 50.51 | 27667366 | |
662 | Ubiquitination | KAKERAFKRQFVEHA HHHHHHHHHHHHHHH | 44.28 | 29967540 | |
719 (in isoform 1) | Ubiquitination | - | 41.88 | 21890473 | |
719 | Ubiquitination | QEIAAMNKKIEVLDS HHHHHHHHHHHHHHH | 41.88 | 21906983 | |
720 | Ubiquitination | EIAAMNKKIEVLDSL HHHHHHHHHHHHHHH | 38.81 | 21906983 | |
720 (in isoform 1) | Ubiquitination | - | 38.81 | 21890473 | |
730 (in isoform 1) | Ubiquitination | - | 36.26 | 21890473 | |
730 | Ubiquitination | VLDSLQSKAKLLRNK HHHHHHHHHHHHHHC | 36.26 | 21906983 | |
732 | Ubiquitination | DSLQSKAKLLRNKAG HHHHHHHHHHHHCCC | 52.36 | 22817900 | |
737 (in isoform 1) | Ubiquitination | - | 41.67 | 21890473 | |
737 | Ubiquitination | KAKLLRNKAGWLDSE HHHHHHHCCCCHHHH | 41.67 | 21963094 | |
756 | Phosphorylation | THQYLQPSR------ HHHHCCCCC------ | 37.35 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
27 | S | Phosphorylation | Kinase | MAPK9 | P45984-2 | GPS |
111 | T | Phosphorylation | Kinase | PINK1 | Q9BXM7 | Uniprot |
442 | S | Phosphorylation | Kinase | PINK1 | Q9BXM7 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | MARCHF5 | Q9NX47 | PMID:23727017 |
- | K | Ubiquitination | E3 ubiquitin ligase | PRKN | O60260 | PMID:20871098 |
- | K | Ubiquitination | E3 ubiquitin ligase | AMFR | Q9UKV5 | PMID:23427266 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MFN2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MFN2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HUWE1_HUMAN | HUWE1 | physical | 22748923 | |
MARH5_HUMAN | MARCH5 | physical | 23727017 | |
MFN2_HUMAN | MFN2 | physical | 23727017 | |
HDAC6_HUMAN | HDAC6 | physical | 26210454 | |
MARH5_HUMAN | MARCH5 | physical | 26210454 | |
S2538_HUMAN | SLC25A38 | physical | 26813789 | |
MFN1_HUMAN | MFN1 | physical | 27713096 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atroph | |||||
OMIM Disease | ||||||
609260 | Charcot-Marie-Tooth disease 2A2 (CMT2A2) | |||||
601152 | Charcot-Marie-Tooth disease 6 (CMT6) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-243, AND MASS SPECTROMETRY. |